^
    BIOMARKER:
    HER-2 amplification
    i
    Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
    Entrez ID:
    2064
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    HER-2 amplification
    Hormone Receptor Positive Breast Cancer
    Trazimera (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    HER2 Positive Breast Cancer
    Trazimera (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    Hormone Receptor Positive Breast Cancer
    Ontruzant (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    HER2 Positive Breast Cancer
    Ontruzant (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    Hormone Receptor Positive Breast Cancer
    Ogivri (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    HER2 Positive Breast Cancer
    Ogivri (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    Hormone Receptor Positive Breast Cancer
    Kanjinti (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    HER2 Positive Breast Cancer
    Kanjinti (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    Hormone Receptor Positive Breast Cancer
    Herzuma (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    HER2 Positive Breast Cancer
    Herzuma (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    Hormone Receptor Positive Breast Cancer
    neratinib
    Sensitive
    :
    A1
    HER-2 amplification
    Breast Cancer
    Zercepac (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 amplification
    CRC
    trastuzumab + pertuzumab
    Sensitive
    :
    A2
    HER-2 amplification
    CRC
    fam-trastuzumab deruxtecan-nxki
    Sensitive
    :
    A2
    HER-2 amplification
    CRC
    trastuzumab + lapatinib
    Sensitive
    :
    A2
    HER-2 amplification
    Gastric Cancer
    trastuzumab
    Sensitive
    :
    B
    HER-2 amplification
    HER2 Positive Breast Cancer
    trastuzumab
    Sensitive
    :
    B
    HER-2 amplification
    Gastroesophageal Junction Adenocarcinoma
    trastuzumab
    Sensitive
    :
    B
    HER-2 amplification
    Gastric Cancer
    lapatinib
    Sensitive
    :
    B
    HER-2 amplification
    Breast Cancer
    neratinib
    Sensitive
    :
    C1
    HER-2 amplification
    Breast Cancer
    lapatinib
    Sensitive
    :
    C2
    HER-2 amplification
    Breast Cancer
    tucatinib
    Sensitive
    :
    C2
    HER-2 amplification
    Gastric Cancer
    pembrolizumab + trastuzumab
    Sensitive
    :
    C2
    HER-2 amplification
    Cholangiocarcinoma
    trastuzumab
    Sensitive
    :
    C2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES